Dual antenatal HIV and syphilis testing cost effective

  • PDF / 186,495 Bytes
  • 1 Pages / 595.245 x 841.846 pts (A4) Page_size
  • 13 Downloads / 196 Views

DOWNLOAD

REPORT

PharmacoEconomics & Outcomes News 867, p12 - 28 Nov 2020 Dual antenatal HIV and syphilis testing cost effective Antenatal testing with a dual rapid diagnostic test for both HIV and syphilis, to prevent mother-to-child transmission (MTCT) of the diseases, appears to be cost saving in Colombia, Kenya, South Africa and Ukraine, according to findings of a study published in The Lancet Global Health which was funded by the WHO, the US Agency for International Development, and the Bill & Melinda Gates Foundation. Markov models of HIV and syphilis in pregnant women were used to compare the cost effectiveness of four strategies for HIV and syphilis testing in Colombia and Ukraine, which have a low HIV prevalence (

Data Loading...

Recommend Documents
Mobile-based HIV counselling and testing cost effective in Ethiopia

174 69 182KB

Syphilis in HIV/AIDS Patients

145 57 54MB

Comparison of HIV Prevalence Among Antenatal Clinic Attendees Estimated from Routine Testing and Unlinked Anonymous Test

147 50 1MB

HIV screening 3-monthly cost effective in young MSM

158 95 182KB

HIV Testing

179 94 2MB

Factors associated with HIV and syphilis screenings among pregnant women at first antenatal visit in Lusaka, Zambia

110 25 741KB

Cost-Effective

168 109 57MB

Highly Cost-Effective Intervention

195 83 57MB

Atomoxetine cost-effective in ADHD

158 88 139KB

Atorvastatin cost effective in T2DM

163 57 182KB

Syphilis

144 63 722KB

Expanded testing for COVID-19 could be cost effective in USA

172 45 182KB